tetano
Editor, Senior Moderator
Vascular
. 2022 Sep 8;17085381221126235.
doi: 10.1177/17085381221126235. Online ahead of print.
Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies
Mateo Porres-Aguilar[SUP] 1 [/SUP], Debabrata Mukherjee[SUP] 2 [/SUP], S Claudia Didia[SUP] 1 [/SUP], Alejandro Lazo-Langner[SUP] 3 [/SUP]
Affiliations
Abstract
Novel coronavirus 2019 (COVID-19) represents a significant risk factor for the development of venous thromboembolism (VTE) in hospitalized with both moderate and severe/critical COVID-19. Herein, we present a brief updated review on emerging robust data on diverse thromboprophylaxis strategies used to mitigate VTE complications, as well as a personal point of view of current controversies in regards the use of therapeutic and prophylactic anticoagulation strategies, particularly in the moderately-ill subgroup of patients with COVID-19.
Keywords: COVID-19; heparins; outcomes; therapeutic anticoagulation; thromboprophylaxis; venous thromboembolism.
. 2022 Sep 8;17085381221126235.
doi: 10.1177/17085381221126235. Online ahead of print.
Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies
Mateo Porres-Aguilar[SUP] 1 [/SUP], Debabrata Mukherjee[SUP] 2 [/SUP], S Claudia Didia[SUP] 1 [/SUP], Alejandro Lazo-Langner[SUP] 3 [/SUP]
Affiliations
- PMID: 36076354
- DOI: 10.1177/17085381221126235
Abstract
Novel coronavirus 2019 (COVID-19) represents a significant risk factor for the development of venous thromboembolism (VTE) in hospitalized with both moderate and severe/critical COVID-19. Herein, we present a brief updated review on emerging robust data on diverse thromboprophylaxis strategies used to mitigate VTE complications, as well as a personal point of view of current controversies in regards the use of therapeutic and prophylactic anticoagulation strategies, particularly in the moderately-ill subgroup of patients with COVID-19.
Keywords: COVID-19; heparins; outcomes; therapeutic anticoagulation; thromboprophylaxis; venous thromboembolism.